Purpose: To assess the performance of the Brief Sexual Symptom Checklist for men (BSSC-M) questionnaire in General Practitioner’s (GP) consults in Spain. Methods: Multicenter, cross-sectional study conducted in Spain among men ≥50 years, visiting a GP for any reason, and being able to answer self-administered questionnaires. Patients receiving medicines for erectile dysfunction (ED) and those with poor functional status were excluded. Sexual satisfaction was assessed by the BSSC-M, ED by the Sexual Health Inventory for Men (SHIM), and quality of life (QoL) using a 5-point Likert scale. Results: In all, 770 men met all the selection criteria and 556 patients (72.2%) reported sexually related problems, ED being the most frequent (n = 427; 55.5%). The SHIM score decreased progressively with the number of causes of sexual dissatisfaction. Prevalence of ED (SHIM ≤21) was greater in patients who referred problems with erection in the BSSC-M questionnaire (76 vs. 14%; p < 0.001). Multivariate analysis for ED prediction revealed that sexual dissatisfaction, QoL (average or low/very low), and the presence of 3 or more comorbidities significantly influenced the chances of having ED. Conclusions: Our results encourage the use of the BSSC-M for identifying suspicion of ED and other sexual problems in patients > 50 who visit their GP for a routine follow-up.

Keywords:
Sexual satisfaction, Erectile dysfunction, Primary care, Quality of life
1.
McCabe MP, Sharlip ID, Lewis R, Atalla E, Balon R, Fisher AD, et al: Incidence and prevalence of sexual dysfunction in women and men: a consensus statement from the fourth international consultation on sexual medicine 2015. J Sex Med 2016; 13: 144–152.
2.
Mercer CH, Fenton KA, Johnson AM, Wellings K, Macdowall W, McManus S, et al: Sexual function problems and help seeking behaviour in Britain: national probability sample survey. BMJ 2003; 327: 426–427.
3.
Hinchliff S, Gott M: Seeking medical help for sexual concerns in mid- and later life: a review of the literature. J Sex Res 2011; 48: 106–117.
4.
Hatzichristou D, Rosen RC, Broderick G, Clayton A, Cuzin B, Derogatis L, et al: Clinical evaluation and management strategy for sexual dysfunction in men and women. J Sex Med 2004; 1: 49–57.
5.
Hatzichristou D, Rosen RC, Derogatis LR, Low WY, Meuleman EJ, Sadovsky R, et al: Recommendations for the clinical evaluation of men and women with sexual dysfunction. J Sex Med 2010; 7: 337–348.
6.
Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A: The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822–830.
7.
Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM: Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999; 11: 319–326.
8.
Hackett G: The use of questionnaires to assess sexual function. Trends Urol Men’s Heal 2017; 8: 17–20.
9.
Cappelleri JC, Rosen RC: The sexual health inventory for men (SHIM): a 5-year review of research and clinical experience. Int J Impot Res 2005; 17: 307–319.
10.
Moncada I, Micheltorena CF, Martínez-Sánchez EM, Gutiérrez JR: Evaluation of the psychometric properties of the life satisfaction checklist as a screening tool for erectile dysfunction. J Sex Med 2008; 5: 83–91.
11.
Fox C: Questionnaire development: 3. Translation. J Health Soc Policy 1987; 136: 39–48.
12.
Castellanos-Torres E, Álvarez-Dardet C, Ruiz-Muñoz D, Pérez G: Social determinants of sexual satisfaction in Spain considered from the gender perspective. Ann Epidemiol 2013; 23: 150–156.
13.
Chang SC, Klein C, Gorzalka BB: Perceived prevalence and definitions of sexual dysfunction as predictors of sexual function and satisfaction. J Sex Res 2012; 4499: 1–11.
14.
Fisher WA, Donahue KL, Long JS, Heiman JR, Rosen RC, Sand MS: Individual and partner correlates of sexual satisfaction and relationship happiness in midlife couples: dyadic analysis of the international durvey of relationships. Arch Sex Behav 2014; 44: 1609–1620.
15.
Holmberg D, Blair KL: Sexual desire, communication, satisfaction, and preferences of men and women in same-sex versus mixed-sex relationships. J Sex Res 2009; 46: 57–66.
16.
Guo YN, Ng EML, Chan K: Foreplay, orgasm and after-play among Shanghai couples and its integrative relation with their marital satisfaction. Sex Relatsh Ther 2004; 19: 65–78.
17.
Mcclelland SI: Intimate justice: a critical analysis of sexual satisfaction. Soc Personal Psychol Compass 2010; 4: 663–680.
18.
Snell WE, Fisher TD, Walters AS: Sexual abuse: a journal of research and treatment. Sex Abus A J Res Treat 1993; 6: 27–55.
19.
Stulhofer A, Busko V, Brouillard P: Development and bicultural validation of the new sexual satisfaction scale. J Sex Res 2010; 47: 257–268.
20.
Sánchez-Fuentes Mdel M, Santos-Iglesias P, Sierra JC: A systematic review of sexual satisfaction. Int J Clin Heal Psychol 2014; 14: 67–75.
21.
Althof SE, Buvat J, Gutkin SW, Belger M, Stothard DR, Fugl-Meyer AR: Sexual satisfaction in men with erectile dysfunction: correlates and potential predictors. J Sex Med 2010; 7: 203–215.
22.
Velten J, Margraf J: Satisfaction guaranteed? How individual, partner, and relationship factors impact sexual satisfaction within partnerships. PLoS One 2016; 12:e0172855.
23.
Abdo CHN, Afif-Abdo J, Otani F, Machado AC: Sexual satisfaction among patients with erectile dysfunction treated with counseling, sildenafil, or both J Sex Med 2008; 5: 1720–1726.
24.
Menard J, Tremeaux JC, Faix A, Pierrevelcin J, Staerman F: Erectile function and sexual satisfaction before and after penile prosthesis implantation in radical prostatectomy patients: a comparison with patients with vasculogenic erectile dysfunction. J Sex Med 2011; 8: 3479–3486.
25.
Raina R, Agarwal A, Allamaneni SS, Lakin MM, Zippe CD: Sildenafil citrate and vacuum constriction device combination enhances sexual satisfaction in erectile dysfunction after radical prostatectomy. Urology 2005; 65: 360–364.
26.
Rosen RC, Shabsigh R, Kuritzky L, Wang WC, Sides GD: The efficacy of tadalafil in improving sexual satisfaction and overall satisfaction in men with mild, moderate, and severe erectile dysfunction: a retrospective pooled analysis of data from randomized, placebo-controlled clinical trials. Curr Med Res Opin 2005; 21: 1701–1709.
27.
García-Cruz E, Carrión A, Ajami T, Álvarez M, Correas MÁ, García B, et al: The patient’s comorbidity burden correlates with the erectile dysfunction severity. Actas Urol Esp 2018; 42: 57–63.
28.
Paduch DA, Bolyakov A, Beardsworth A, Watts SD: Factors associated with ejaculatory and orgasmic dysfunction in men with erectile dysfunction: analysis of clinical trials involving the phosphodiesterase type 5 inhibitor tadalafil. BJU Int 2012; 109: 1060–1067.
29.
Baldwin DS, Manson C, Nowak M: Impact of antidepressant drugs on sexual function and satisfaction. CNS Drugs 2015; 29: 905–913.
30.
Hatzimouratidis K, Eardley I, Giuliano F, Moncada I, Salonia A: Male sexual dysfunction: erectile dysfunction and premature ejaculation [Internet]. 2015 [cited 2017 Jun 7]. Available from: http://uroweb.org/wp-content/uploads/14-Male-Sexual-Dysfunction_LR1.pdf.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.